Occasional drinking and regular drinking carry different health concerns
The semaglutide plateau phenomenon also deserves mention here
Gene regulation resetting the cellular clock Perhaps the most remarkable aspect of GHK-Cu is its influence on gene expression
This is risky for several reasons: Wrong patient selection, such as people with pancreatitis, gallstones, or severe kidney disease using them without screening Rapid, unsupervised dose escalation No monitoring of kidney, liver, pancreatic, or eye status Complications seen with unsupervised use include pancreatitis, dehydration-induced acute kidney injury (especially in hot Indian summers with vomiting or diarrhoea), and even diabetic ketoacidosis in susceptible individuals
About half (54%) of those who report ever taking the drugs say it was difficult to afford them, including one in five (22%) who say it was very difficult. Having insurance coverage makes little difference to patients perceptions of the drugs affordability, with similar shares of those covered by insurance saying the drugs were difficult (53%) or very difficult (23%) to afford
Indeed, at their peak in 2024, nearly 1 in 3 Americans taking a GLP-1 drug said they were getting it from a compounding pharmacy